Valuation: Cencora, Inc.

Market Cap 59.35B 52.22B 48.53B 44.56B 83.64B 5,731B 85.04B 576B 226B 2,809B 223B 218B 9,721B P/E 2026 *
17.2x
P/E 2027 * 18.3x
Enterprise Value 63.73B 56.08B 52.12B 47.85B 89.81B 6,154B 91.32B 619B 243B 3,016B 239B 234B 10,439B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.18x
Free-Float
62.46%
Yield 2026 *
0.77%
Yield 2027 * 0.79%
1 day+1.84%
1 week+1.19%
Current month+9.86%
1 month+10.22%
3 months+2.18%
6 months-8.79%
Current year-4.98%
1 week 263.6
Extreme 263.6
272.2
1 month 246.8
Extreme 246.8
272.2
Current year 216.4
Extreme 216.4
320.9
1 year 216.4
Extreme 216.4
325.35
3 years 161.46
Extreme 161.46
325.35
5 years 137.06
Extreme 137.06
325.35
10 years 137.06
Extreme 137.06
325.35
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+1.19% - - 59.35B
+2.29%+4.28%-18.10%-9.83% 175B
+1.46%-0.42%-9.56%-6.46% 105B
-1.13%-1.96%+32.11%+56.38% 50.71B
+2.22%-2.23%-14.36%-40.96% 42.15B
+2.98%-5.74% - - 31.82B
+1.50%-8.26%-17.23%-45.22% 27.2B
-7.67%-9.45%+44.38%-13.02% 25.11B
+1.63%-3.19%-5.06%-7.76% 20.53B
+0.30%-1.93%-12.56%-1.07% 19.42B
Average +0.54%-3.56%-0.05%-8.49% 55.27B
Weighted average by Cap. +1.23%-1.61%-6.14%-6.46%

Financials

2026 *2027 *
Net sales 337B 296B 275B 253B 475B 32,528B 483B 3,272B 1,282B 15,945B 1,265B 1,237B 55,180B 358B 315B 293B 269B 505B 34,569B 513B 3,477B 1,363B 16,945B 1,344B 1,315B 58,642B
Net income 3.47B 3.05B 2.84B 2.61B 4.89B 335B 4.97B 33.71B 13.21B 164B 13.03B 12.75B 569B 2.98B 2.62B 2.44B 2.24B 4.2B 288B 4.27B 28.96B 11.35B 141B 11.19B 10.95B 488B
Net Debt 4.38B 3.85B 3.58B 3.29B 6.17B 423B 6.28B 42.54B 16.68B 207B 16.45B 16.09B 718B 5.34B 4.7B 4.37B 4.01B 7.52B 516B 7.65B 51.85B 20.32B 253B 20.04B 19.61B 875B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
26-07-24 €271.80 +1.84%
26-07-23 €266.90 +1.25%
26-07-22 €263.60 -0.83%
26-07-21 €265.80 -0.26%
26-07-20 €266.50 -0.56%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
305.06USD
Average target price
355.83USD
Spread / Average Target
+16.64%

Quarterly revenue - Rate of surprise